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silent and, when not associated with 
outbreaks, most likely neglected by 
local physicians.
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Meningitis Caused 
by Streptococcus 
suis Serotype 14, 
North America
To the Editor: Streptococcus suis 
is an opportunistic pathogen that can 
cause serious systemic infections in 
pigs and occupation-related infections 
in humans who work in close contact 
with pigs or pork by-products. Most S. 
suis organisms isolated from diseased 
pigs belong to serotypes 1–8 (1). The 
most prevalent strain worldwide is se-
rotype 2, which causes invasive infec-
tions in pigs and humans (2). We report 
a case of human meningitis caused by 
S. suis serotype 14.
The patient was a 59-year-old 
woman from rural Manitoba, Canada; 
she worked at a hog plant and handled 
300–400 piglets/day. In October 2007, 
when she sought care, she had a 2-day 
history of fever, vomiting, headache, 
neck pain, and reduced consciousness. 
She was febrile and confused and had 
meningeal signs. Leukocyte count 
was 19,900/mm3. Cerebrospinal fl uid 
(CSF) had 284 × 106/L leukocytes 
(59% lymphocytes, 41% polymorpho-
nuclear cells), 2.3 mmol/L glucose, 
and 1.85 g/L total protein. Gram stain 
of CSF showed gram-positive cocci 
in pairs; cefotaxime and vancomycin 
were prescribed empirically. Results 
of computed tomography of the head, 
chest radiograph, and transesophageal 
echocardiogram were within normal 
limits. Blood culture was negative af-
ter 5 days of incubation. The CSF cul-
ture grew small α-hemolytic colonies 
on blood agar and chocolate agar. The 
organisms were gram-positive cocci 
in chains, were catalase negative, and 
were identifi ed as S. suis by Vitek II 
and API 20 Strep System (both from 
bioMérieux, St.-Laurent, Quebec City, 
Canada).
Identifi cation of the organism as 
S. suis was confi rmed at the National 
Microbiology Laboratory, Winnipeg, 
Manitoba, Canada, by conventional 
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biochemical tests (3), the results of 
which were consistent with that of the 
type strain (Table) and were also con-
fi rmed by 16S rRNA gene sequencing, 
which showed 100% homology with 
the S. suis type strain ATCC 43765, 
GenBank accession no. EU 477176.
Antimicrobial-drug susceptibili-
ties were determined by microbroth 
dilution by using Sensititre STP3F 
panels (Nova Century Scientifi c Inc., 
Burlington, Ontario, Canada) and cat-
ion-adjusted Mueller Hinton broth with 
lysed horse blood (2%–5% vol/vol) by 
TREK Diagnostic Systems, Inc. (Nova 
Century Scientifi c Inc.) using manu-
facturer’s instructions and following 
Clinical and Laboratory Standards 
Institute guidelines for Streptococcus 
spp. other than S. pneumoniae (4). 
This isolate was sensitive to penicil-
lin, cefepime, cefotaxime, ceftriaxone, 
linezolid, trimethoprim and sulfame-
thoxazole, vancomycin, meropenem, 
and levofl oxacin; it was resistant to 
azithromycin, erythromycin, and tet-
racycline. The isolate was sent to the 
International Reference Laboratory at 
the Université de Montréal, Montréal, 
Québec, Canada, for S. suis serotyping, 
where it was identifi ed by the coagglu-
tination test as serotype 14 (5).
The patient recovered quickly, and 
her therapy was changed to penicillin 
G. She was transferred to her local hos-
pital to complete her medication. With-
in a week of her initial visit, bilateral 
deafness and loss of balance developed 
and progressed over the next month 
and had not ameliorated after 1 year.
Human S. suis infections result 
primarily from direct contact (with 
wounds on skin or mucosa of the mouth 
and nasal cavity) with carrier pigs, sick 
pigs, or raw pork contaminated with S. 
suis (2). The infection rate among ab-
attoir workers, pig breeders, meat pro-
cessing workers, and veterinarians is 
≈3 cases/100,000 (1,500× higher than 
the rate for the general population) (2). 
A striking sequela to S. suis meningitis 
is deafness or vestibular dysfunction 
(2,6). A consistently higher percentage 
of persons experienced deafness after 
S. suis infection than after infection 
with other meningitis-causing bacte-
ria, 50% and 65% in Europe and Asia, 
respectively (2).
Most cases of S. suis infection in 
humans have been attributed to sero-
type 2 strains. Only 4 human cases 
have been reported in North America: 
2 in Canada (1 endocarditis, 1 menin-
gitis) and 2 cases of meningitis in the 
United States (6–9). All 4 cases were 
attributed to S. suis serotype 2. Sero-
type 14 has been reported as a human 
pathogen in the Netherlands, Thailand, 
the United Kingdom, and Denmark 
and has been routinely isolated from 
diseased pigs in Canada (10). 
Although in pigs the organism is 
present in the upper respiratory tract, 
particularly the tonsils, nasal cavities, 
genital tract, and alimentary tract, the 
mode of transmission to humans re-
ported so far had been through cuts in 
the hands. Our patient handled hun-
dreds of piglets every day and most 
likely acquired the infection through 
her hands. Her meningitis was com-
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Table. Identification of organism isolated from cerebrospinal fluid of 59-year-old woman 
with meningitis, Manitoba, Canada* 
Test Streptococcus suis (3) Patient isolate 
Į-hemolysis on sheep blood agar + +
Motility – –
Catalase – –
Oxidase ND –
Fermented 
L-arabinose – –
D-glucose + +
 Glycerol – –
 Inulin + +
 Lactose + +
 Maltose + +
 Mannitol – –
 Melezitose – –
 Melibiose Variable +
 Raffinose Variable +
 Ribose – –
 Salicin + +
 Sorbitol – –
 Sucrose + +
 Trehalose + +
Hydrolyzed 
L-arginine + –
 Esculin/bile esculin +/ND ±
 Starch + +
 Glycogen + +
 Hippurate – –
Acetoin – –
Optochin disk Resistant ND
Enzymes  
Į-galactosidase + +
ȕ-galactosidase Variable +
ȕ-glucuronidase + +
 Leucine arylamidase + +
 N-acetylglucosaminidase + +
 Acid phosphatase – –
 Alkaline phosphatase – –
 Pyrrolidonylarylamidase – –
API Strep code  4640473 high degree 
(97%) confidence S. suis
*+, positive; –, negative; ND, not done; API Strep code, API 20 Strep, API System (bioMérieux, St.-
Laurent, Quebec City, Canada).  
LETTERS
plicated by bilateral hearing loss with 
vestibular dysfunction. Preexisting 
medical conditions, such as alcohol-
ism, liver cirrhosis, or splenectomy, 
have been described to predispose pa-
tients to severe infection and hearing 
loss (2). Our patient, however, did not 
have any predisposing conditions.
Meningitis in humans caused by 
S. suis serotype 14 is less common 
than that caused by serotype 2, but 
the consequences are similar and can 
be reduced by early treatment with 
antimicrobial drugs. Identifying this 
case of meningitis caused by S. suis 
serotype 14 in Canada raises concerns 
about the public health aspect of this 
infection. Guidelines may be required 
to ensure that staff working in hog 
plants are aware of the risk for this 
infection and that they use adequate 
personal protective equipment. 
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Outbreaks Caused 
by New Variants of 
Vibrio cholerae O1 
El Tor, India 
To the Editor: Vibrio cholerae 
O1, the causative agent of cholera, 
has 2 biotypes (classical and El Tor), 
which have traditionally been distin-
guished by phenotypic tests and by 
genetic differences in the major toxin-
coregulated pilus (TCP) gene, the tcpA 
allele of the TCP cluster (1), the rstR 
region (regulatory region for phage ly-
sogeny) of CTX phages (2), the type 
of cholera toxin (CT) produced, and 
the infection pattern of the disease 
they cause. However, 3 variants of the 
El Tor biotype have been described re-
cently: Matlab (a place in Bangladesh) 
variants in 2002 (3), which could not 
be biotyped because they have a mix-
ture of both classical and El Tor (4), 
Mozambique variant in 2004–2005, 
which has a typical El Tor genome but 
a tandem repeat of the classical CTX 
prophage in the small chromosome 
(5), and the altered El Tor type (a typi-
cal El Tor biotype and an El Tor CTX 
prophage that produces CT of the clas-
sical type) predominant in Bangladesh 
since 2001 (6). Hybrid vibrios have 
also been described in other regions of 
Asia and Africa (7).
CT, encoded by the ctxA and ctxB 
genes, is the principal toxin produced 
by V. cholerae O1 and O139. Methods 
for differentiating the biotype-specifi c 
CT-B subunit of V. cholerae O1 in-
clude sequencing the ctxB gene, per-
forming an ELISA wth a monoclonal 
antibody specifi c to the classical or El 
Tor CT, or by using a mismatch am-
plifi cation mutation assay (MAMA)–
PCR to distinguish between 2 kinds 
of ctxB genes. This assay detects se-
quence polymorphisms based on nt 
position 203 of the ctxB gene (8).
In Punjab and Haryana states of 
northern India, during July–Septem-
ber 2007, 6 clusters of cholera out-
break were identifi ed. A total of 745 
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